Researchers Develop Highly Accurate Modeling Tool to Predict COVID-19 Risk

As new coronavirus variants emerge and quickly spread around the globe, both the public and policymakers are faced with a quandary: maintaining a semblance of normality, while also minimizing infections. While digital contact tracing apps offered promise, the adoption rate has been low, due in part to privacy concerns.

At USC, researchers are advocating for a new approach to predict the chance of infection from COVID-19: combining anonymized cellphone location data with mobility patterns - broad patterns of how people move from place to place.

To produce "risk scores" for specific locations and times, the team used a large dataset of anonymous, real-world location signals from cell phones across the US in 2019 and 2020. The system shows a 50% improvement in accuracy compared to current systems, said the researchers.

"Our results show that it is possible to predict and target specific areas that are high-risk, as opposed to putting all businesses under one umbrella. Such risk-targeted policies can be significantly more effective, both for controlling COVID-19 and economically," said lead author Sepanta Zeighami, a computer science Ph.D. student advised by Professor Cyrus Shahabi.

"It's also unlikely that COVID-19 will be the last pandemic in human history, so if we want to avoid the chaos of 2020 and the tragic losses while keeping daily life as unaffected as possible when the next pandemic happens, we need such data-driven approaches."

To address privacy concerns, the mobility data comes in an aggregated format, allowing the researchers to see patterns without identifying individual users. The data is not being used for contact tracing, identifying infected individuals, or where they are going, said the researchers.

"Our approach relies on anonymized aggregate data," said Shahabi, study co-author and Helen N. and Emmett H. Jones Professor in Engineering and Professor of Computer Science, Electrical and Computer Engineering, and Spatial Sciences. "It is the same as traffic data, where an individual’s information is not revealed, but the aggregate data will help you to make a decision on whether to use a certain freeway at a certain time."

The paper will appear in the ACM Transactions on Spatial Algorithms and Systems.

Data-driven approaches

According to the researchers, existing risk score tools do not provide enough detailed information about infection rates at specific places, or they make unrealistic assumptions about how populations mix.

"The risk of infection varies a lot based on the location, and having a single policy, for instance, at a county level, ignores how some areas are riskier than others," said Zeighami.

So, using real-world mobility data and existing knowledge about the spread of COVID-19, the team created a simulator to generate realistic infection patterns. In the simulation, some “agents” are initially infected and spread the disease as they move around.

Then, the researchers created a Hawkes process-based model, which assigns risk scores based on location density and mobility patterns at a given time and place. Using the simulator, the researchers tested the model to determine if it could accurately predict the number of infections at different locations. It turned out, the risk scores were indeed a reliable metric for tracking infections in cities across the US, including San Francisco, New York, Chicago and Los Angeles.

The researchers found, predictably, that popular destinations in a city are riskier. But they also found that incorporating the infection mobility - how people move - as opposed to just relying on the popularity of an area helped to improve infection prediction. This, said the researchers, underscores the importance of bringing together mobility patterns and infection spread prediction models to generate risk scores.

There are two key ways the system could be used in the real world, said the researchers. The more straightforward case is to make neighborhood-level policy decisions: for instance, bars in Santa Monica, CA, should close today due to high risk in that neighborhood.

For more targeted locations, such as a specific concert stadium event, the system would crunch the mobility data from similar concerts in the past to learn how the infection risk changes in the area following this type of event. Then, using the researchers’ model and current mobility data across LA, the system could make predictions and assign risk scores.

Going forward, the team plans to develop user-specific, yet still privacy-preserving, risk scores, and to include long-term forecasting capabilities for several weeks into the future.

"The very high resolution of this mobility data, as well as our scalable approach, will enable us to estimate risk scores at a very fine-grain spatial and temporal resolution, for example, a specific restaurant at dinner time, or a shopping mall at lunchtime," said Shahabi.

"As an individual, you may want to avoid areas deemed high-risk, and policymakers could warn the public to avoid an area known to be a potential hotspot of infection. The scores can also be used for closure or reduced capacity decisions. Instead of making these decisions at the county level, public health experts can make those decisions at city, neighborhood or zip code levels."

Sirisha Rambhatla, Sepanta Zeighami, Kameron Shahabi, Cyrus Shahabi, Yan Liu.
Toward Accurate Spatiotemporal COVID-19 Risk Scores Using High-Resolution Real-World Mobility Data.
ACM Transactions on Spatial Algorithms and Systems, Volume 8, Issue 2, 2022. doi: https://doi.org/10.1145/3481044

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...